http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0236734-A3

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-86
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-64
filingDate 1987-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1988-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0236734-A3
titleOfInvention 5-Amino-4-hydroxyvaleryl derivatives substituted by s-containing groups
abstract Compounds of the formula wherein R₁ by a thio, sulfinyl or sulfonyl group substituted acyl, A an optionally N-alkylated α-amino acid residue which is N-terminally connected to R₁ and C-terminally to the group -NR₂-, R₂ is hydrogen or lower alkyl, R₃ is hydrogen, lower alkyl, optionally etherified or esterified hydroxy-lower alkyl, cycloalkyl, cycloalkyl-lower alkyl, bicycloalkyl-lower alkyl, tri cycloalkyl-lower alkyl, aryl or aryl-lower alkyl, R₄ hydroxy, etherified or esterified hydroxy, R₅ lower alkyl, optionally etherified alkyl, cyclo-cyclo, bicyclo-alkyl, esterified cyclo, bicycloalkyl, esterified or cyclo-hydroxyalkyl, cycloalkyl-lower alkyl, tricycloalkyl, tricycloalkyl-lower alkyl, aryl, aryl-lower alkyl, optionally substituted carbamoyl, optionally substituted amino, optionally substituted hydroxyl or optionally substituted mercapto, sulfinyl or sulfonyl and R₆ substituted amino, and salts of such compounds with salt-forming compounds Groups inhibit the blood pressure-increasing effects of the enzyme renin and can be used as anti-hypertensives.
priorityDate 1986-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4435329-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0136883-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9TSZ1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP60016
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6DLS0
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A6I8ST60
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP52115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396411
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00797
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455581532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6DLW5
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397808
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6DYE7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF6W228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814463
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310

Total number of triples: 36.